Skip to main content

AMERIPRISE FINANCIAL INC

Position in ANIP — Ani Pharmaceuticals Inc

CIK 820027 MINNEAPOLIS, MN

Position in ANIP

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$20,783,147
-$522,994 QoQ
Shares Held
270,262
+0.1% QoQ
Ownership
1.19%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 96.16594267784593.ToString("F0")% None 3.834057322154058.ToString("F0")%

Common Shares in ANIP Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

AMERIPRISE FINANCIAL INC holds $745,649,307 across 34 Drug Manufacturers - Specialty & Generic names. ANIP ranks #7 (2.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 ANIP
Ani Pharmaceuticals Inc
This page
270,262 $20,783,147

All Filings in ANIP

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $20,783,147 270,262
2025-12-31 $21,306,141 269,903
2025-09-30 $26,732,635 291,841
2025-06-30 $24,964,323 382,595
2025-03-31 $26,166,201 390,832
2024-12-31 $15,025,379 271,805
2024-09-30 $14,152,485 237,219
2024-06-30 $14,859,982 233,354
2024-03-31 $16,817,531 243,274
2023-12-31 $13,034,764 236,394
2023-09-30 $14,364,797 247,413
2023-06-30 $13,883,402 257,912
2023-03-31 $11,978,161 301,565
2022-12-31 $12,133,166 301,595
2022-09-30 $9,841,589 306,210
2022-06-30 $9,005,082 303,508
2022-03-31 $8,811,726 313,473
2021-12-31 $13,044,188 283,077
2021-09-30 $8,990,874 273,945
2021-06-30 $9,648,108 275,267
2021-03-31 $8,794,054 243,333
2020-12-31 $6,785,079 233,646
2020-09-30 $5,889,486 208,773
2020-06-30 $1,732,292 53,565
2020-03-31 $2,307,635 56,643